Fagan Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,515
| Closed | -$488K | – | 114 |
|
|
2023
Q3 | $488K | Buy |
6,515
+770
| +13% | +$57.7K | 0.12% | 82 |
|
|
2023
Q2 | $443K | Buy |
5,745
+600
| +12% | +$46.2K | 0.11% | 85 |
|
|
2023
Q1 | $427K | Buy |
5,145
+1,679
| +48% | +$139K | 0.11% | 92 |
|
|
2022
Q4 | $298K | Buy |
+3,466
| New | +$298K | 0.08% | 104 |
|
|
2018
Q1 | – | Sell |
-34,594
| Closed | -$2.48K | – | 105 |
|
|
2017
Q4 | $2.48K | Buy |
34,594
+155
| +0.5% | +$11 | 1% | 30 |
|
|
2017
Q3 | $2.79M | Buy |
34,439
+1,364
| +4% | +$111K | 1.38% | 26 |
|
|
2017
Q2 | $2.34M | Buy |
33,075
+845
| +3% | +$59.8K | 1.22% | 30 |
|
|
2017
Q1 | $2.19M | Sell |
32,230
-870
| -3% | -$59.1K | 1.21% | 28 |
|
|
2016
Q4 | $2.37M | Buy |
33,100
+320
| +1% | +$22.9K | 1.37% | 26 |
|
|
2016
Q3 | $2.59M | Sell |
32,780
-5,385
| -14% | -$426K | 1.59% | 23 |
|
|
2016
Q2 | $3.18M | Buy |
+38,165
| New | +$3.18M | 2.05% | 16 |
|
|
2015
Q3 | – | Sell |
-62,655
| Closed | -$7.34M | – | 92 |
|
|
2015
Q2 | $7.34M | Buy |
+62,655
| New | +$7.34M | 4.89% | 2 |
|
|
2014
Q2 | – | Sell |
-64,835
| Closed | -$4.6M | – | 89 |
|
|
2014
Q1 | $4.6M | Buy |
+64,835
| New | +$4.6M | 3.98% | 4 |
|